Victoria Parker
I am an experienced early clinical development (ECD) leader with a special focus on metabolic diseases. In this role, I am team lead for metabolism physicians and member of the early CVRM and ECD leadership teams. I am also responsible for defining and delivering the clinical research programmes for targets starting in the preclinical space all the way through to phase 2b, as well as supporting the overall clinical development programme to launch. My team and I work closely with a network of scientific advisory boards, global experts and study investigators to help inform the design, monitoring, and results interpretation of clinical studies.
I am a trained consultant in general internal medicine, endocrinology and pharmaceutical medicine. I also completed a PhD in clinical biochemistry and have a special interest in metabolism/endocrinology and rare diseases in this space. I joined AstraZeneca in 2016 and bring extensive early phase (First-In-Human to Ph2b) clinical trial experience and a strong track record in delivering high quality and robust study results. My therapy area expertise spans type 2 diabetes (T2D), chronic kidney disease (CKD), liver diseases, obesity and cardiovascular diseases.
I am deeply committed to building strong and diverse teams and enjoy my role as a mentor and coach for physicians and emerging talent in clinical research. For me, this is key to driving the science forward, through leveraging the talent and expertise of individuals with a shared passion for science and commitment to patient centricity.
It’s hugely rewarding to be at the forefront of developing new medicines for patients in one of the most exciting and innovative areas of clinical research, and to work with accomplished colleagues and clinical researchers globally.
CURRENT ROLE
2023-Present
2021-2023
2020
Featured publications
Veeva ID: Z4-59738
Date if preparation: November 2023